ASX - By Stock
|
MDC |
Re:
Ann: NASDAQ Progression - Medlab Clears SEC Comments
|
|
Apse
|
14 |
4.2K |
5 |
15/12/22 |
15/12/22 |
ASX - By Stock
|
14
|
4.2K
|
5
|
|
ASX - By Stock
|
MDC |
Re:
Ann: NASDAQ Progression - Medlab Clears SEC Comments
|
|
Apse
|
14 |
4.2K |
2 |
09/12/22 |
09/12/22 |
ASX - By Stock
|
14
|
4.2K
|
2
|
|
ASX - By Stock
|
MDC |
Re:
Ann: NASDAQ Progression - Medlab Clears SEC Comments
|
|
Apse
|
14 |
4.2K |
2 |
09/12/22 |
09/12/22 |
ASX - By Stock
|
14
|
4.2K
|
2
|
|
ASX - By Stock
|
MDC |
Re:
Ann: NASDAQ Progression - Medlab Clears SEC Comments
|
|
Apse
|
14 |
4.2K |
0 |
09/12/22 |
09/12/22 |
ASX - By Stock
|
14
|
4.2K
|
0
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Apse
|
55 |
12K |
3 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
55
|
12K
|
3
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Apse
|
55 |
12K |
3 |
03/11/22 |
03/11/22 |
ASX - By Stock
|
55
|
12K
|
3
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Apse
|
55 |
12K |
3 |
03/11/22 |
03/11/22 |
ASX - By Stock
|
55
|
12K
|
3
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Apse
|
55 |
12K |
4 |
03/11/22 |
03/11/22 |
ASX - By Stock
|
55
|
12K
|
4
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Biotech Investors' Conference Presentation
|
|
Apse
|
15 |
3.5K |
4 |
25/08/22 |
25/08/22 |
ASX - By Stock
|
15
|
3.5K
|
4
|
|
ASX - By Stock
|
MAG |
Re:
Ann: Visible Cu Sulphides Intersected Over 740m Interval at Myall
|
|
Apse
|
184 |
69K |
15 |
23/08/22 |
23/08/22 |
ASX - By Stock
|
184
|
69K
|
15
|
|
ASX - By Stock
|
MAG |
Re:
Ann: Trading Halt
|
|
Apse
|
49 |
14K |
15 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
49
|
14K
|
15
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Biotech Investors' Conference Presentation
|
|
Apse
|
15 |
3.5K |
3 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
15
|
3.5K
|
3
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Biotech Investors' Conference Presentation
|
|
Apse
|
15 |
3.5K |
3 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
15
|
3.5K
|
3
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Share Consolidation update & despatch of holding statements
|
|
Apse
|
9 |
3.0K |
5 |
09/08/22 |
09/08/22 |
ASX - By Stock
|
9
|
3.0K
|
5
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Share Consolidation update & despatch of holding statements
|
|
Apse
|
9 |
3.0K |
1 |
09/08/22 |
09/08/22 |
ASX - By Stock
|
9
|
3.0K
|
1
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Share Consolidation update & despatch of holding statements
|
|
Apse
|
9 |
3.0K |
1 |
09/08/22 |
09/08/22 |
ASX - By Stock
|
9
|
3.0K
|
1
|
|
ASX - By Stock
|
MDC |
Re:
Ann: UNSW Medlab Laboratory Collaboration Additional Information
|
|
Apse
|
27 |
5.5K |
2 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
27
|
5.5K
|
2
|
|
ASX - By Stock
|
MDC |
Re:
Ann: UNSW Medlab Laboratory Collaboration Additional Information
|
|
Apse
|
27 |
5.5K |
1 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
27
|
5.5K
|
1
|
|
ASX - By Stock
|
MDC |
Re:
Ann: UNSW Medlab Laboratory Collaboration Additional Information
|
|
Apse
|
27 |
5.5K |
3 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
27
|
5.5K
|
3
|
|
ASX - By Stock
|
MDC |
Re:
Ann: UNSW Medlab Laboratory Collaboration Additional Information
|
|
Apse
|
27 |
5.5K |
3 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
27
|
5.5K
|
3
|
|
ASX - By Stock
|
MDC |
Re:
Ann: UNSW Medlab Laboratory Collaboration Additional Information
|
|
Apse
|
27 |
5.5K |
2 |
02/08/22 |
02/08/22 |
ASX - By Stock
|
27
|
5.5K
|
2
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Apse
|
4 |
1.1K |
3 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
4
|
1.1K
|
3
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Results of MDC July 2022 EGM
|
|
Apse
|
13 |
3.8K |
2 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
13
|
3.8K
|
2
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Results of MDC July 2022 EGM
|
|
Apse
|
13 |
3.8K |
4 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
13
|
3.8K
|
4
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Results of MDC July 2022 EGM
|
|
Apse
|
13 |
3.8K |
2 |
28/07/22 |
28/07/22 |
ASX - By Stock
|
13
|
3.8K
|
2
|
|
ASX - By Stock
|
MDC |
Re:
Nanabis - now with synthetic CBD
|
|
Apse
|
10 |
2.5K |
4 |
25/07/22 |
25/07/22 |
ASX - By Stock
|
10
|
2.5K
|
4
|
|
ASX - By Stock
|
MDC |
Re:
Nanabis - now with synthetic CBD
|
|
Apse
|
10 |
2.5K |
5 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
10
|
2.5K
|
5
|
|
ASX - By Stock
|
MDC |
Re:
Ann: EGM Notice of Meeting to Approve Dual Listing to Nasdaq
|
|
Apse
|
25 |
7.6K |
4 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
25
|
7.6K
|
4
|
|
ASX - By Stock
|
MDC |
Re:
Ann: EGM Notice of Meeting to Approve Dual Listing to Nasdaq
|
|
Apse
|
25 |
7.6K |
2 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
25
|
7.6K
|
2
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Pause in Trading
|
|
Apse
|
18 |
3.6K |
7 |
28/06/22 |
28/06/22 |
ASX - By Stock
|
18
|
3.6K
|
7
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Apse
|
45 |
13K |
7 |
15/04/22 |
15/04/22 |
ASX - By Stock
|
45
|
13K
|
7
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Half Yearly Report and Accounts
|
|
Apse
|
52 |
14K |
6 |
24/03/22 |
24/03/22 |
ASX - By Stock
|
52
|
14K
|
6
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Half Yearly Report and Accounts
|
|
Apse
|
52 |
14K |
6 |
22/03/22 |
22/03/22 |
ASX - By Stock
|
52
|
14K
|
6
|
|
ASX - By Stock
|
MAG |
Re:
Ann: Bodangora Goldfield Exploration Update
|
|
Apse
|
220 |
57K |
6 |
01/03/22 |
01/03/22 |
ASX - By Stock
|
220
|
57K
|
6
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Medlab Receives AusIndustry Overseas (R&D) Finding Approval
|
|
Apse
|
6 |
1.7K |
3 |
03/11/21 |
03/11/21 |
ASX - By Stock
|
6
|
1.7K
|
3
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Medlab Receives AusIndustry Overseas (R&D) Finding Approval
|
|
Apse
|
6 |
1.7K |
6 |
03/11/21 |
03/11/21 |
ASX - By Stock
|
6
|
1.7K
|
6
|
|
ASX - By Stock
|
ALK |
Re:
Ann: Mineralised System Continues to Grow at Boda
|
|
Apse
|
59 |
23K |
20 |
22/10/21 |
22/10/21 |
ASX - By Stock
|
59
|
23K
|
20
|
|
ASX - By Stock
|
MAG |
Re:
Ann: Broad gold zones expand Lady Ilse Target
|
|
Apse
|
111 |
29K |
13 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
111
|
29K
|
13
|
|
ASX - By Stock
|
ARV |
Re:
Ann: Carlow Castle Update and Proposed Capital Raise
|
|
Apse
|
117 |
57K |
6 |
20/05/21 |
20/05/21 |
ASX - By Stock
|
117
|
57K
|
6
|
|
ASX - By Stock
|
ARV |
Re:
Ann: Trading Halt
|
|
Apse
|
54 |
27K |
1 |
20/05/21 |
20/05/21 |
ASX - By Stock
|
54
|
27K
|
1
|
|
ASX - By Stock
|
ARV |
Re:
Ann: Suspension from Official Quotation
|
|
Apse
|
18 |
8.7K |
0 |
20/05/21 |
20/05/21 |
ASX - By Stock
|
18
|
8.7K
|
0
|
|
ASX - By Stock
|
DVP |
Re:
Mr VXR, Bill Beament
|
|
Apse
|
320 |
147K |
9 |
05/05/21 |
05/05/21 |
ASX - By Stock
|
320
|
147K
|
9
|
|
ASX - By Stock
|
DVP |
Re:
Mr VXR, Bill Beament
|
|
Apse
|
320 |
147K |
2 |
05/05/21 |
05/05/21 |
ASX - By Stock
|
320
|
147K
|
2
|
|
ASX - By Stock
|
DVP |
Re:
Mr VXR, Bill Beament
|
|
Apse
|
320 |
147K |
7 |
05/05/21 |
05/05/21 |
ASX - By Stock
|
320
|
147K
|
7
|
|
ASX - By Stock
|
DVP |
Re:
Mr VXR, Bill Beament
|
|
Apse
|
320 |
147K |
4 |
05/05/21 |
05/05/21 |
ASX - By Stock
|
320
|
147K
|
4
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Reminder of Investor Webinar - NanaBis Phase III Trial
|
|
Apse
|
19 |
4.3K |
6 |
23/04/21 |
23/04/21 |
ASX - By Stock
|
19
|
4.3K
|
6
|
|
ASX - By Stock
|
FRB |
Re:
IPO - Firebird Metals Limited - 19 March 2021 #
|
|
Apse
|
90 |
54K |
8 |
22/03/21 |
22/03/21 |
ASX - By Stock
|
90
|
54K
|
8
|
|
ASX - By Stock
|
DEG |
Re:
Ann: Pause in Trading
|
|
Apse
|
78 |
43K |
5 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
78
|
43K
|
5
|
|
ASX - By Stock
|
DEG |
Re:
Ann: Pause in Trading
|
|
Apse
|
78 |
43K |
5 |
16/04/20 |
16/04/20 |
ASX - By Stock
|
78
|
43K
|
5
|
|
ASX - By Stock
|
DEG |
Re:
Ann: Major extension of sulphide mineralisation at Hemi
|
|
Apse
|
249 |
6.3M |
5 |
26/02/20 |
26/02/20 |
ASX - By Stock
|
249
|
6.3M
|
5
|
|